<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; CMED</title>
	<atom:link href="http://www.stockbloghub.com/tag/cmed/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CMED) China Medical Technologies Collaborates to Grow</title>
		<link>http://www.stockbloghub.com/2011/06/26/cmed-china-medical-technologies-collaborates-to-grow/77425</link>
		<comments>http://www.stockbloghub.com/2011/06/26/cmed-china-medical-technologies-collaborates-to-grow/77425#comments</comments>
		<pubDate>Sun, 26 Jun 2011 17:44:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BEC]]></category>
		<category><![CDATA[Beckman Coulter Inc]]></category>
		<category><![CDATA[China Medical Technologies Inc]]></category>
		<category><![CDATA[CMED]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77425</guid>
		<description><![CDATA[China Medical Technologies, Inc. (CMED), a Chinese in-vitro diagnostic firm, recently revealed that its whole subsidiary – Beijing GP Medical Technologies Co. Ltd. (&#8220;GP Medical&#8221;) has agreed to collaborate with Gaoxin Da An Healthcare Investment Ltd. (&#8220;Da An Health&#8221;) and jointly market and promote molecular diagnostic know-how for clinical diagnostic applications in China. The two partners will work to introduce novel molecular diagnostic products to serve Da An Health&#8217;s hospital clients and leverage Da An Health&#8217;s network of labs for validation of new products. The agreement includes provisions for expanding the scope of the agreement from molecular diagnostic products to the entire product lineup of GP Medical. The Chairman and CEO of China Medical Technologies stated that the collaboration will lead to greater brand recognition and product awareness among a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/26/cmed-china-medical-technologies-collaborates-to-grow/77425/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>($AZN) Profit From Health Care Reform in China</title>
		<link>http://www.stockbloghub.com/2010/03/08/azn-profit-from-health-care-reform-in-china/29956</link>
		<comments>http://www.stockbloghub.com/2010/03/08/azn-profit-from-health-care-reform-in-china/29956#comments</comments>
		<pubDate>Mon, 08 Mar 2010 15:25:08 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AstraZeneca plc]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[China Medical Technologies Inc]]></category>
		<category><![CDATA[CMED]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Mindray Medical International Limited]]></category>
		<category><![CDATA[MR]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sanofi-Aventis]]></category>
		<category><![CDATA[SNY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29956</guid>
		<description><![CDATA[It’s safe to say that the financial media is obsessed with four subjects these days: Economic stimulus, healthcare reform, Greece and China. And let’s face it: After the eighth, seventeenth or twenty-fifth article on the same topics, it starts to get a bit boring. Combine three out of those four subjects together though, and it becomes much more interesting… especially considering that unlike what the United States implemented, China’s $586 billion stimulus package focused on repairing the weak links in its economy Incorporatedluding its healthcare system. Over the next three years, the Chinese government pledged $123 billion towards a variety of medical programs Incorporatedluding ones that target waste and distortions in prescriptions and treatment. China also plans to use 2010 to build some 29,000 medical centers and 2,000 hospitals, while ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/08/azn-profit-from-health-care-reform-in-china/29956/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SNDA) 4 Chinese Growth Stocks &#8211; Investment Ideas</title>
		<link>http://www.stockbloghub.com/2009/09/17/snda-4-chinese-growth-stocks-investment-ideas/15440</link>
		<comments>http://www.stockbloghub.com/2009/09/17/snda-4-chinese-growth-stocks-investment-ideas/15440#comments</comments>
		<pubDate>Thu, 17 Sep 2009 18:50:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[China Medical Technologies Inc]]></category>
		<category><![CDATA[CMED]]></category>
		<category><![CDATA[RINO]]></category>
		<category><![CDATA[Rino International Corporation]]></category>
		<category><![CDATA[Shanda Interactive Entertainme]]></category>
		<category><![CDATA[SNDA]]></category>
		<category><![CDATA[WATG]]></category>
		<category><![CDATA[Wonder Auto Technology Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=15440</guid>
		<description><![CDATA[It&#8217;s no secret that Chinese stocks have been pumping out massive gains over the last few years, barring last fall&#8217;s global economic meltdown. And now that the country is on the cusp of eclipsing Japan as the world&#8217;s #2 economy, the song is much the same. While many other countries continue to struggle under the weight of a global recession, China is on pace to post GDP growth of more than 8% this year. The country&#8217;s torrid growth trajectory is being fueled by a few key factors. Key Factors Driving China&#8217;s Growth First and foremost, China has firmly established itself as a manufacturing powerhouse, accounting for 9% of the world&#8217;s exports. That strong manufacturing base has given rise to a consumer class that is demanding both regular and premium products ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/17/snda-4-chinese-growth-stocks-investment-ideas/15440/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

